Literature DB >> 7633715

Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.

H Mukae1, J Kadota, S Kohno, S Kusano, T Morikawa, S Matsukura, K Hara.   

Abstract

To study the role of T cells in diffuse panbronchiolitis (DPB), we investigated T-cell subsets in bronchoalveolar lavage fluid (BALF) or 33 patients with DPB, nine patients with bronchiectasis, and 20 healthy volunteers. BALF from DPB patients contained a higher percentage of neutrophils than that from patients with bronchiectasis or healthy volunteers, whereas the percentage of lymphocytes was similar in the three groups. DPB patients, however, had a higher number of lymphocytes and a reduced CD4/CD8 ratio compared with the other subjects. A two-color analysis of T-cell subsets in peripheral blood and BALF revealed a significant increase in the percentage and number of CD8+HLA-DR+ cells and in the number of CD4+HLA-DR+ cells in BALF of DPB patients. The expression of the adhesion molecules CD 11a and CD18 on lung CD3+ cells was enhanced over that on blood CD3+ cells in DPB patients. However, there was no significant difference in the expression of these antigens in peripheral blood or BALF among the groups. There was no significant relationship between BALF interleukin (IL)-8 and lymphocyte accumulation in the lungs of the DPB patients, whereas a significant correlation between the percentage of neutrophils and IL-8 levels in BALF of DPB patients was observed. After treatment with macrolide antibiotics, a significant reduction in the number of lymphocytes and activated CD8+ cells and an elevation in the CD4/CD8 ratio in BALF of DPB patients was observed. Our findings suggest an activation of CD8+ cells in the airway lumen of DPB patients, supporting the hypothesis that lymphocytes are important cellular components of bronchial inflammation in DPB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633715     DOI: 10.1164/ajrccm.152.2.7633715

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.

Authors:  Dianhua Jiang; Jiurong Liang; Rishu Guo; Ting Xie; Francine L Kelly; Tereza Martinu; Ting Yang; Alysia K Lovgren; Jessica Chia; Ningshan Liu; Yoosun Jung; Scott M Palmer; Paul W Noble
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

Review 2.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 3.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

5.  Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.

Authors:  M Gaga; A M Bentley; M Humbert; J Barkans; F O'Brien; C G Wathen; A B Kay; S R Durham
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

6.  Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.

Authors:  T Hiratsuka; H Mukae; H Iiboshi; J Ashitani; K Nabeshima; T Minematsu; N Chino; T Ihi; S Kohno; M Nakazato
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

7.  Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis.

Authors:  M Yamamoto; W Matsuyama; K Oonakahara; M Watanabe; I Higashimoto; M Kawabata; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

8.  Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.

Authors:  H Mukae; H Iiboshi; M Nakazato; T Hiratsuka; M Tokojima; K Abe; J Ashitani; J Kadota; S Matsukura; S Kohno
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

9.  High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia.

Authors:  H Ishii; H Mukae; J Kadota; H Kaida; T Nagata; K Abe; S Matsukura; S Kohno
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.